Literature DB >> 10395857

Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.

B K Eriksson1, J Andersson, S E Holm, M Norgren.   

Abstract

Analysis of 132 group A streptococcal (GAS) isolates from 151 invasive episodes, including streptococcal toxic shock syndrome (STSS), from 1983 to 1995 showed great genetic variation by use of T serotyping in combination with restriction fragment length polymorphism. In contrast, genetically homogenous T1M1 isolates appeared in epidemic patterns with significantly increased risk of STSS. The speA gene, with the allelic variants speA2 and speA3 carried by the T1M1 and T3M3 serotypes, respectively, was strongly associated with STSS. Infection with a GAS isolate carrying speA, alcohol abuse, and malignancy recently treated with cytostatic drugs were factors independently related to STSS. Neutralization of SpeA lymphocyte mitogenicity was totally absent in sera from patients with STSS and low in sera from persons with uncomplicated bacteremia compared with levels in sera from uncomplicated erysipelas. Neutralization of SpeB was significantly lower in sera of patients with STSS than in sera from persons with bacteremia or erysipelas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395857     DOI: 10.1086/314872

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden.

Authors:  A Jasir; A Tanna; A Efstratiou; C Schalén
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

3.  Streptococcal pyrogenic exotoxin B-induced apoptosis in a549 cells is mediated by a receptor- and mitochondrion-dependent pathway.

Authors:  Wan-Hua Tsai; Chia-Wen Chang; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Wen-Tsan Chang; Ming T Lin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome.

Authors:  Lily Yang; Mark Thomas; Andrew Woodhouse; Diana Martin; John D Fraser; Thomas Proft
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Authors:  Tuula Siljander; Outi Lyytikäinen; Susanna Vähäkuopus; Petrus Säilä; Jari Jalava; Jaana Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

6.  Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Authors:  S Rantala; S Vähäkuopus; T Siljander; J Vuopio; H Huhtala; R Vuento; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-30       Impact factor: 3.267

Review 7.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

8.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

9.  Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

Authors:  Samir S Shah; Matthew Hall; Raj Srivastava; Anupama Subramony; James E Levin
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

10.  Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.

Authors:  Chih-Feng Kuo; Yee-Shin Lin; Woei-Jer Chuang; Jiunn-Jong Wu; Nina Tsao
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.